Related Experiment Videos
Network-based drug repurposing for MYH9-related nephritis
Muhammad Ali1, Tommaso Gili2, Guido Caldarelli1,3,4
1Ca'Foscari University of Venice, DSMN, Italy.
Abstract:
Using tools from network theory, we analyze the organization of a MYH9-oriented druglike library in chemical space using a multidescriptor framework. The dataset is drawn from ZINC, a publicly available database of commercially accessible compounds curated for virtual screening and drug discovery. Starting from 6004 molecules, preprocessing yields 5000 structurally valid and descriptor-complete compounds. Similarity is defined via Tanimoto distance on Morgan fingerprints and single-descriptor distances for xLogP, HBD, HBA, molecular weight, and rotatable bonds. For each representation we construct k-nearest-neighbor networks and identify communities using the Louvain-Leiden algorithm. All networks exhibit highly significant modularity (Q=0.91-0.99) relative to degree-preserving null models, demonstrating pronounced nonrandom chemical organization across descriptors. Cross-descriptor robustness is quantified through a coclustering matrix over 1.25×10^{7} molecular pairs, measuring how consistently compound pairs co-occur within the same community across descriptor-specific networks. Although most pairs show limited agreement, a sparse high-consensus core emerges, highlighting the complementarity of the descriptors. Minimum spanning trees derived from structural and consensus similarities reveal distinct backbone topologies: a scaffold-driven, sparse structure versus a compact, hub-rich consensus network. Betweenness centrality on these backbones identifies compounds that are both structurally central and descriptor-balanced. These results provide a statistically validated network representation of chemical space and a principled strategy to extract consensus-stable compounds for downstream screening.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Pharmacogenomics: Identification of New Drug Targets
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System